Health-related quality of life (HR-QOL) and chronic health conditions in survivors of childhood acute myeloid leukemia (AML) with down syndrome (DS): A report from the children's oncology group

Kris Ann P Schultz, Lu Chen, Alicia Kunin-Batson, Zhengjia Chen, William G. Woods, Alan Gamis, Toana Kawashima, Kevin C. Oeffinger, H. Stacy Nicholson, Joseph P. Neglia

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Survival rates for children with Down syndrome (DS) and acute myeloid leukemia (AML) are high; however, little is known regarding the health-related quality of life (HR-QOL) of these survivors. Individuals who survived Z5 years following diagnosis of childhood AML were invited to complete parent or patient-report surveys measuring HR-QOL and chronic health conditions. In total, 26 individuals with DS had a median age at diagnosis of 1.8 years (range, 0.77 to 10.9 y) and median age at interview of 15 years (range, 8.3 to 27.6 y). Participants with DS and AML were compared with AML survivors without DS whose caregiver completed a HR-QOL survey (CHQ-PF50). In total, 77% of survivors with DS reported Z1 chronic health condition compared with 50% of AML survivors without DS (P=0.07). Mean physical and psychosocial QOL scores for children with DS and AML were statistically lower than the population mean, though not discrepant from AML survivors without DS. Although the overall prevalence of chronic health conditions in survivors with DS is higher than in survivors without DS, prior studies of children with DS have reported similarly high rates of chronic health conditions, suggesting that AML therapy may not substantially increase this risk.

Original languageEnglish (US)
Pages (from-to)20-25
Number of pages6
JournalJournal of pediatric hematology/oncology
Volume39
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Down Syndrome
Acute Myeloid Leukemia
Survivors
Quality of Life
Health
Caregivers
Survival Rate
Interviews

Keywords

  • Chemotherapy
  • Down syndrome
  • Leukemia
  • Quality of life

Cite this

Health-related quality of life (HR-QOL) and chronic health conditions in survivors of childhood acute myeloid leukemia (AML) with down syndrome (DS) : A report from the children's oncology group. / Schultz, Kris Ann P; Chen, Lu; Kunin-Batson, Alicia; Chen, Zhengjia; Woods, William G.; Gamis, Alan; Kawashima, Toana; Oeffinger, Kevin C.; Nicholson, H. Stacy; Neglia, Joseph P.

In: Journal of pediatric hematology/oncology, Vol. 39, No. 1, 01.01.2017, p. 20-25.

Research output: Contribution to journalArticle

Schultz, Kris Ann P ; Chen, Lu ; Kunin-Batson, Alicia ; Chen, Zhengjia ; Woods, William G. ; Gamis, Alan ; Kawashima, Toana ; Oeffinger, Kevin C. ; Nicholson, H. Stacy ; Neglia, Joseph P. / Health-related quality of life (HR-QOL) and chronic health conditions in survivors of childhood acute myeloid leukemia (AML) with down syndrome (DS) : A report from the children's oncology group. In: Journal of pediatric hematology/oncology. 2017 ; Vol. 39, No. 1. pp. 20-25.
@article{6350d59465394eb0b715cbaaa32682f6,
title = "Health-related quality of life (HR-QOL) and chronic health conditions in survivors of childhood acute myeloid leukemia (AML) with down syndrome (DS): A report from the children's oncology group",
abstract = "Survival rates for children with Down syndrome (DS) and acute myeloid leukemia (AML) are high; however, little is known regarding the health-related quality of life (HR-QOL) of these survivors. Individuals who survived Z5 years following diagnosis of childhood AML were invited to complete parent or patient-report surveys measuring HR-QOL and chronic health conditions. In total, 26 individuals with DS had a median age at diagnosis of 1.8 years (range, 0.77 to 10.9 y) and median age at interview of 15 years (range, 8.3 to 27.6 y). Participants with DS and AML were compared with AML survivors without DS whose caregiver completed a HR-QOL survey (CHQ-PF50). In total, 77{\%} of survivors with DS reported Z1 chronic health condition compared with 50{\%} of AML survivors without DS (P=0.07). Mean physical and psychosocial QOL scores for children with DS and AML were statistically lower than the population mean, though not discrepant from AML survivors without DS. Although the overall prevalence of chronic health conditions in survivors with DS is higher than in survivors without DS, prior studies of children with DS have reported similarly high rates of chronic health conditions, suggesting that AML therapy may not substantially increase this risk.",
keywords = "Chemotherapy, Down syndrome, Leukemia, Quality of life",
author = "Schultz, {Kris Ann P} and Lu Chen and Alicia Kunin-Batson and Zhengjia Chen and Woods, {William G.} and Alan Gamis and Toana Kawashima and Oeffinger, {Kevin C.} and Nicholson, {H. Stacy} and Neglia, {Joseph P.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1097/MPH.0000000000000707",
language = "English (US)",
volume = "39",
pages = "20--25",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Health-related quality of life (HR-QOL) and chronic health conditions in survivors of childhood acute myeloid leukemia (AML) with down syndrome (DS)

T2 - A report from the children's oncology group

AU - Schultz, Kris Ann P

AU - Chen, Lu

AU - Kunin-Batson, Alicia

AU - Chen, Zhengjia

AU - Woods, William G.

AU - Gamis, Alan

AU - Kawashima, Toana

AU - Oeffinger, Kevin C.

AU - Nicholson, H. Stacy

AU - Neglia, Joseph P.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Survival rates for children with Down syndrome (DS) and acute myeloid leukemia (AML) are high; however, little is known regarding the health-related quality of life (HR-QOL) of these survivors. Individuals who survived Z5 years following diagnosis of childhood AML were invited to complete parent or patient-report surveys measuring HR-QOL and chronic health conditions. In total, 26 individuals with DS had a median age at diagnosis of 1.8 years (range, 0.77 to 10.9 y) and median age at interview of 15 years (range, 8.3 to 27.6 y). Participants with DS and AML were compared with AML survivors without DS whose caregiver completed a HR-QOL survey (CHQ-PF50). In total, 77% of survivors with DS reported Z1 chronic health condition compared with 50% of AML survivors without DS (P=0.07). Mean physical and psychosocial QOL scores for children with DS and AML were statistically lower than the population mean, though not discrepant from AML survivors without DS. Although the overall prevalence of chronic health conditions in survivors with DS is higher than in survivors without DS, prior studies of children with DS have reported similarly high rates of chronic health conditions, suggesting that AML therapy may not substantially increase this risk.

AB - Survival rates for children with Down syndrome (DS) and acute myeloid leukemia (AML) are high; however, little is known regarding the health-related quality of life (HR-QOL) of these survivors. Individuals who survived Z5 years following diagnosis of childhood AML were invited to complete parent or patient-report surveys measuring HR-QOL and chronic health conditions. In total, 26 individuals with DS had a median age at diagnosis of 1.8 years (range, 0.77 to 10.9 y) and median age at interview of 15 years (range, 8.3 to 27.6 y). Participants with DS and AML were compared with AML survivors without DS whose caregiver completed a HR-QOL survey (CHQ-PF50). In total, 77% of survivors with DS reported Z1 chronic health condition compared with 50% of AML survivors without DS (P=0.07). Mean physical and psychosocial QOL scores for children with DS and AML were statistically lower than the population mean, though not discrepant from AML survivors without DS. Although the overall prevalence of chronic health conditions in survivors with DS is higher than in survivors without DS, prior studies of children with DS have reported similarly high rates of chronic health conditions, suggesting that AML therapy may not substantially increase this risk.

KW - Chemotherapy

KW - Down syndrome

KW - Leukemia

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=85000962066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85000962066&partnerID=8YFLogxK

U2 - 10.1097/MPH.0000000000000707

DO - 10.1097/MPH.0000000000000707

M3 - Article

C2 - 27906794

AN - SCOPUS:85000962066

VL - 39

SP - 20

EP - 25

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 1

ER -